Alleyn T Plowright

Hypothesis driven drug design: improving quality and effectiveness of the design-make-test-analyse cycle.

R. A. Thompson, Jonas Pettersson, Jan Kihlberg, 2012, Drug discovery today.

Oxadiazoles in medicinal chemistry.

Jonas Boström, Anders Hogner, Alleyn T Plowright, 2012, Journal of medicinal chemistry.

Skeletal diversity construction via a branching synthetic strategy.

Suzanne Fergus, Andreas Bender, David R Spring, 2006, Chemical communications.

Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis.

David R Spring, Martin Welch, Warren R J D Galloway, 2008, Chemical communications.

Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest

David E James, Benjamin L Parker, James E Hudson, 2017, Proceedings of the National Academy of Sciences.

New Modalities for Challenging Targets in Drug Discovery.

Herbert Waldmann, Stéphanie M. Guéret, Alleyn T Plowright, 2017, Angewandte Chemie.

Discovery of AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP) for the treatment of inflammatory diseases.

Susanne Winiwarter, Johan Ulander, Anna Pettersen, 2015, Journal of medicinal chemistry.